High Beta-Agonist Users in Five HMOs: Implications Beyond High Beta-Agonist Use

High Beta-Agonist Users in Five HMOs: Implications Beyond High Beta-Agonist Use

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of allergy, asthma, & immunology asthma, & immunology, 1996-02, Vol.76 (2), p.125-127
1. Verfasser: Pearlman, David S.
Format: Artikel
Sprache:eng
Schlagworte:
Adrenergic beta-Agonists - therapeutic use
Asthma - drug therapy
Drug Utilization
Health Maintenance Organizations - trends
Humans
National Institutes of Health (U.S.)
Practice Guidelines as Topic
United States
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 127
container_issue 2
container_start_page 125
container_title Annals of allergy, asthma, & immunology
container_volume 76
creator Pearlman, David S.
description
doi_str_mv 10.1016/S1081-1206(10)63410-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77955100</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1081120610634102</els_id><sourcerecordid>77955100</sourcerecordid><originalsourceid>FETCH-LOGICAL-c308t-c8568b50e4b3c8fa3aae9475dd64e95de26ef7fd47e92997c364315c28976c2a3</originalsourceid><addsrcrecordid>eNqFkMtKA0EQRRtRYox-QmBWoovRfs-0G4nBmEAkC8266XTXxJZ5xOlJIH_v5KErwVUVVffWpQ5CfYLvCCby_o3glMSEYnlD8K1knOCYnqAuEYzHnDN52vY_knN0EcInxpikknVQJxVKCKq6aDb2y4_oCRoTD5ZV6UMTzQPUIfJlNPIbiMavs_AQTYpV7q1pfFWGVr2tShf96bxEZ5nJA1wdaw_NR8_vw3E8nb1MhoNpbBlOm9imQqYLgYEvmE0zw4wBxRPhnOSghAMqIUsyxxNQVKnEMskZEZamKpGWGtZD14e7q7r6WkNodOGDhTw3JVTroJOkfZBg3ArFQWjrKoQaMr2qfWHqrSZY70DqPUi9o7Qb7UFq2vr6x4D1ogD36zqSa_ePhz20X2481DpYD6UF52uwjXaV_yfhG5lBgKg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77955100</pqid></control><display><type>article</type><title>High Beta-Agonist Users in Five HMOs: Implications Beyond High Beta-Agonist Use</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Pearlman, David S.</creator><creatorcontrib>Pearlman, David S.</creatorcontrib><identifier>ISSN: 1081-1206</identifier><identifier>EISSN: 1534-4436</identifier><identifier>DOI: 10.1016/S1081-1206(10)63410-2</identifier><identifier>PMID: 8595529</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adrenergic beta-Agonists - therapeutic use ; Asthma - drug therapy ; Drug Utilization ; Health Maintenance Organizations - trends ; Humans ; National Institutes of Health (U.S.) ; Practice Guidelines as Topic ; United States</subject><ispartof>Annals of allergy, asthma, &amp; immunology, 1996-02, Vol.76 (2), p.125-127</ispartof><rights>1996 American College of Allergy, Asthma &amp; Immunology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c308t-c8568b50e4b3c8fa3aae9475dd64e95de26ef7fd47e92997c364315c28976c2a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S1081-1206(10)63410-2$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8595529$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pearlman, David S.</creatorcontrib><title>High Beta-Agonist Users in Five HMOs: Implications Beyond High Beta-Agonist Use</title><title>Annals of allergy, asthma, &amp; immunology</title><addtitle>Ann Allergy Asthma Immunol</addtitle><subject>Adrenergic beta-Agonists - therapeutic use</subject><subject>Asthma - drug therapy</subject><subject>Drug Utilization</subject><subject>Health Maintenance Organizations - trends</subject><subject>Humans</subject><subject>National Institutes of Health (U.S.)</subject><subject>Practice Guidelines as Topic</subject><subject>United States</subject><issn>1081-1206</issn><issn>1534-4436</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtKA0EQRRtRYox-QmBWoovRfs-0G4nBmEAkC8266XTXxJZ5xOlJIH_v5KErwVUVVffWpQ5CfYLvCCby_o3glMSEYnlD8K1knOCYnqAuEYzHnDN52vY_knN0EcInxpikknVQJxVKCKq6aDb2y4_oCRoTD5ZV6UMTzQPUIfJlNPIbiMavs_AQTYpV7q1pfFWGVr2tShf96bxEZ5nJA1wdaw_NR8_vw3E8nb1MhoNpbBlOm9imQqYLgYEvmE0zw4wBxRPhnOSghAMqIUsyxxNQVKnEMskZEZamKpGWGtZD14e7q7r6WkNodOGDhTw3JVTroJOkfZBg3ArFQWjrKoQaMr2qfWHqrSZY70DqPUi9o7Qb7UFq2vr6x4D1ogD36zqSa_ePhz20X2481DpYD6UF52uwjXaV_yfhG5lBgKg</recordid><startdate>19960201</startdate><enddate>19960201</enddate><creator>Pearlman, David S.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960201</creationdate><title>High Beta-Agonist Users in Five HMOs: Implications Beyond High Beta-Agonist Use</title><author>Pearlman, David S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c308t-c8568b50e4b3c8fa3aae9475dd64e95de26ef7fd47e92997c364315c28976c2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adrenergic beta-Agonists - therapeutic use</topic><topic>Asthma - drug therapy</topic><topic>Drug Utilization</topic><topic>Health Maintenance Organizations - trends</topic><topic>Humans</topic><topic>National Institutes of Health (U.S.)</topic><topic>Practice Guidelines as Topic</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pearlman, David S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of allergy, asthma, &amp; immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pearlman, David S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High Beta-Agonist Users in Five HMOs: Implications Beyond High Beta-Agonist Use</atitle><jtitle>Annals of allergy, asthma, &amp; immunology</jtitle><addtitle>Ann Allergy Asthma Immunol</addtitle><date>1996-02-01</date><risdate>1996</risdate><volume>76</volume><issue>2</issue><spage>125</spage><epage>127</epage><pages>125-127</pages><issn>1081-1206</issn><eissn>1534-4436</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>8595529</pmid><doi>10.1016/S1081-1206(10)63410-2</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1081-1206
ispartof Annals of allergy, asthma, & immunology, 1996-02, Vol.76 (2), p.125-127
issn 1081-1206
1534-4436
language eng
recordid cdi_proquest_miscellaneous_77955100
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adrenergic beta-Agonists - therapeutic use
Asthma - drug therapy
Drug Utilization
Health Maintenance Organizations - trends
Humans
National Institutes of Health (U.S.)
Practice Guidelines as Topic
United States
title High Beta-Agonist Users in Five HMOs: Implications Beyond High Beta-Agonist Use
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T07%3A51%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20Beta-Agonist%20Users%20in%20Five%20HMOs:%20Implications%20Beyond%20High%20Beta-Agonist%20Use&rft.jtitle=Annals%20of%20allergy,%20asthma,%20&%20immunology&rft.au=Pearlman,%20David%20S.&rft.date=1996-02-01&rft.volume=76&rft.issue=2&rft.spage=125&rft.epage=127&rft.pages=125-127&rft.issn=1081-1206&rft.eissn=1534-4436&rft_id=info:doi/10.1016/S1081-1206(10)63410-2&rft_dat=%3Cproquest_cross%3E77955100%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77955100&rft_id=info:pmid/8595529&rft_els_id=S1081120610634102&rfr_iscdi=true